Serious Adverse Event Reporting
Post on 13-Feb-2016
86 Views
Preview:
DESCRIPTION
Transcript
Serious Adverse Serious Adverse Event ReportingEvent Reporting
Start-up MeetingMarch 25, 2010Kingston, ON
ProceduresProcedures Using Pfizer ProductsUsing Pfizer Products MUSTMUST follow Pfizer SAE reporting follow Pfizer SAE reporting
policiespolicies
SAEs DefinedSAEs Defined Any untoward medical occurrence that Any untoward medical occurrence that at at
any doseany dose results in: results in: DeathDeath Is life-threateningIs life-threatening Requires in-patient hospitalization or prolongs Requires in-patient hospitalization or prolongs
hospitalizationhospitalization Results in persistent or significant Results in persistent or significant
disability/incapacitydisability/incapacity Is a congenital anomaly or birth defectIs a congenital anomaly or birth defect An important medical eventAn important medical event
SAE Manual pg. 4-5
When to report:When to report:
SAE CriteriaReportable (x)
Expected
Unexpected
Death x xLife-threatening xHospitalization xDisability/Incapacity xCongenital anomaly, birth defect
x
Important medical event
x
UNEXPECTEDAn event that is not expected due to the progression of underlying disease or co-
morbid illnesses.
SAE Reports to:SAE Reports to:
Pfizer Canada Drug Safety Group
AND
A copy sent to CERU Project Leader
SAE Manual pg. 7
Reporting TimelinesReporting Timelines From the time the patient receives From the time the patient receives
the first dose until 28 days following the first dose until 28 days following the last dosethe last dose
SAE Manual pg. 6
Consent Obtained
Last Dose of
Investigational ProductRandomizat
ion
28 days post last
dose of IP28 days
Report all SAEs to Pfizer & CERU
14 days
Initial Reports - TimingInitial Reports - Timing Fatal & Life-threatening: Fatal & Life-threatening:
IMMEDIATELYIMMEDIATELY
All other SAEs: within 24 hours of All other SAEs: within 24 hours of awareness of the occurrence of the awareness of the occurrence of the eventevent
SAE Manual pg. 6
SAE Report FormsSAE Report Forms
SAE Manual, Appendix A & B
Minimum required Minimum required informationinformation
1. Identifiable Patient
Minimum required Minimum required informationinformation
2. Suspect Product
Minimum required Minimum required informationinformation
3. SAE (diagnosis or signs & symptoms)
Minimum required Minimum required informationinformation
4. Identifiable reporting source
Causality AssessmentCausality AssessmentA determination of whether or not there is a
reasonable possibility that the blinded therapy is caused or contributed to the SAE.
OR
•Concomitant medications
•Background treatment
•Comorbidities
•Study procedures
•Other
YES
NO
SAE Manual pg. 7
Follow-up InformationFollow-up Information New, updated or corrected New, updated or corrected
information to a previously information to a previously submitted report:submitted report: Missing or incomplete info at time of Missing or incomplete info at time of
initial reportinitial report Info not previously availableInfo not previously available Changes or clarificationsChanges or clarifications Additional information as requested by Additional information as requested by
Pfizer or CERUPfizer or CERU
Site completes an initial report using Pfizer SAE Report Form
Sends report to: Pfizer AND CERU
Site identifies a reportable SAE
Site reports SAE to local REB as per local
requirements
Pfizer will correspond with site until report is
complete
If event is casually related to IP, CERU must report to Health Canada:
•Death or Life-threatening = 7 calendar days
•All other SAEs = 15 calendar days
CERU will correspond with the site until report is complete.
Causally related to IP?
YES & NO
YES
CERU will send completed report to all participating sites. Site to submit to local REB.
UnblindingUnblinding
If there are concerns regarding the If there are concerns regarding the investigational product, stop the product investigational product, stop the product and complete a Protocol Violation Formand complete a Protocol Violation Form
If unblinding is required procedures If unblinding is required procedures outlinedoutlined
SAE Manual pg. 9
There is no known antidote for the investigational products
top related